All articles by Srivani Venna

Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants

French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US, targeting both private healthcare providers…
SBTi approves Piramal Pharma’s GHG reduction targets

The Science Based Targets initiative (SBTi) has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.…
Regeneron’s Dupixent approved as first adolescent CRSwNP treatment

The US Food and Drug Administration (FDA) has expanded the approval of Dupixent (dupilumab) to include adolescents aged 12 to…
Lilly’s EBGLYSS gains FDA approval for patients aged 12 and older

Eli Lilly and Company has announced FDA approval of EBGLYSS (lebrikizumab-lbkz) to treat moderate-to-severe atopic dermatitis in adults and children…
SII and Oxford University’s malaria vax launched in Côte d’Ivoire

The R21/Matrix-M malaria vaccine, co-developed by the Serum Institute of India (SII) and the University of Oxford, has been launched…

AusperBio secures funding to advance AHB-137 for CHB

AusperBio has raised $37m in a Series A financing round to propel the clinical development of AHB-1 for chronic hepatitis…
Sanofi and Biovac partner to produce polio vaccines in Africa

Sanofi and Biovac have announced a partnership to establish the first African-based manufacturing capabilities for inactivated polio vaccines (IPV), marking…
AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex (fulvestrant) in the European Union (EU) for the treatment…
AstraZeneca launches new digital health solutions business Evinova

AstraZeneca has launched Evenova, a new digital health solutions business, within the company to expedite innovation in the life sciences industry. Evinova…
BMS gains breakthrough therapy designation for PPF treatment

Bristol Myers Squibb (BMS) has received breakthrough therapy designation from the US Food and Drug Administration for its investigational therapy…